Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers

19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers
Conditions:   Diffuse Large B Cell Lymphoma;   Primary Mediastinal Large B Cell Lymphoma;   Transformed Follicular Lymphoma to Diffuse Large B Cell Lymphoma;   Chronic Lymphocytic Leukemia;   Indolent Non-Hodgkin Lymphoma;   Marginal Zone Lymphoma;   Waldenstrom Macroglobulinemia;   Burkitt’s Lymphoma;   Primary CNS Lymphoma
Intervention:   Drug: 19(T2)28z1xx CAR T cells
Sponsors:   Memorial Sloan Kettering Cancer Center;   Takeda
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 10, 2020 / by / in
Comments